[
  {
    "ts": null,
    "headline": "8 'Safer' Dividend Buys In Barron's 23 Better Bets (BBB) Than T-Bills August Report",
    "summary": "Discover 23 top dividend stocks with yields over 4.2%âoffering solid income and growth, even as bond yields rise.",
    "url": "https://finnhub.io/api/news?id=78b826f2f4929c04d82d57c22204b78156dff72a52c6b812f318654c556f6845",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756639131,
      "headline": "8 'Safer' Dividend Buys In Barron's 23 Better Bets (BBB) Than T-Bills August Report",
      "id": 136588415,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212827183/image_2212827183.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Discover 23 top dividend stocks with yields over 4.2%âoffering solid income and growth, even as bond yields rise.",
      "url": "https://finnhub.io/api/news?id=78b826f2f4929c04d82d57c22204b78156dff72a52c6b812f318654c556f6845"
    }
  },
  {
    "ts": null,
    "headline": "BMO Capital Maintains a Hold on Bristol-Myers Squibb (BMY)",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the top most undervalued low volatility stocks to buy now. On August 25, BMO Capital analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00. The analyst supported the rating with the present performance and future expectations […]",
    "url": "https://finnhub.io/api/news?id=664d85552680d526687af756244bc4f7b0c19c5a1c961f33fbf96562f5a2fb07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756613442,
      "headline": "BMO Capital Maintains a Hold on Bristol-Myers Squibb (BMY)",
      "id": 136593365,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the top most undervalued low volatility stocks to buy now. On August 25, BMO Capital analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00. The analyst supported the rating with the present performance and future expectations […]",
      "url": "https://finnhub.io/api/news?id=664d85552680d526687af756244bc4f7b0c19c5a1c961f33fbf96562f5a2fb07"
    }
  }
]